Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cheadle

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Cancers|May 4, 2026
The Tumour Immune Microenvironment as a Predictor of the Response to Neoadjuvant Therapy in Rectal CancerSreya Wadud, Eleanor J Cheadle, Paul A Sutton
Journal of Medical Genetics|September 1, 1992
Mutation analysis of 184 cystic fibrosis families in WalesJ Cheadle, J Myring, L al-Jader, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 7, 2005
Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulinAnne C Armstrong, Eleanor J Cheadle, Robert E Hawkins
British Journal of Haematology|May 15, 2008
The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphomaEleanor J Cheadle, David E Gilham, Robert E Hawkins
Immunology|January 10, 2003
Mycobacterium bovis bacillus Calmette-Guérin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanismEleanor J Cheadle, Peter J Selby, Andrew M Jackson
Expert Opinion on Biological Therapy|September 6, 2014
Update on obinutuzumab in the treatment of B-cell malignanciesTim Illidge, Eleanor J Cheadle, Claire Donaghy, et al.
Radiation Oncology (London, England)|November 5, 2020
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinationsMadyson Colton, Eleanor J Cheadle, Jamie Honeychurch, et al.
Journal of Medical Genetics|August 1, 1992
Mild pulmonary disease in a cystic fibrosis child homozygous for R553XJ Cheadle, L al-Jader, M Goodchild, et al.
Infection and Immunity|January 25, 2005
Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cellsEleanor J Cheadle, Dearbhaile O'Donnell, Peter J Selby, et al.
Leukemia & Lymphoma|April 7, 2016
Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignanciesGrazyna Lipowska-Bhalla, Ester Fagnano, Timothy M Illidge, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Cancers|May 4, 2026
The Tumour Immune Microenvironment as a Predictor of the Response to Neoadjuvant Therapy in Rectal CancerSreya Wadud, Eleanor J Cheadle, Paul A Sutton
Journal of Medical Genetics|September 1, 1992
Mutation analysis of 184 cystic fibrosis families in WalesJ Cheadle, J Myring, L al-Jader, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 7, 2005
Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulinAnne C Armstrong, Eleanor J Cheadle, Robert E Hawkins
British Journal of Haematology|May 15, 2008
The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphomaEleanor J Cheadle, David E Gilham, Robert E Hawkins
Immunology|January 10, 2003
Mycobacterium bovis bacillus Calmette-Guérin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanismEleanor J Cheadle, Peter J Selby, Andrew M Jackson
Expert Opinion on Biological Therapy|September 6, 2014
Update on obinutuzumab in the treatment of B-cell malignanciesTim Illidge, Eleanor J Cheadle, Claire Donaghy, et al.
Radiation Oncology (London, England)|November 5, 2020
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinationsMadyson Colton, Eleanor J Cheadle, Jamie Honeychurch, et al.
Journal of Medical Genetics|August 1, 1992
Mild pulmonary disease in a cystic fibrosis child homozygous for R553XJ Cheadle, L al-Jader, M Goodchild, et al.
Infection and Immunity|January 25, 2005
Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cellsEleanor J Cheadle, Dearbhaile O'Donnell, Peter J Selby, et al.
Leukemia & Lymphoma|April 7, 2016
Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignanciesGrazyna Lipowska-Bhalla, Ester Fagnano, Timothy M Illidge, et al.
Pageof 8